LINC01765: A Potential Drug Target and Biomarker (G105378916)

Target Name: LINC01765

NCBI ID: G105378916

LINC01765

Other Name(s): Long intergenic non-protein coding RNA 1765 | long intergenic non-protein coding RNA 1765

LINC01765: A Potential Drug Target and Biomarker

LINC01765 is a long intergenic non-protein coding RNA (lncRNA) that has been identified by bioinformatic analysis as having potential drug targets and biomarker properties. This RNA molecule has been located in various genomic regions and is involved in various cellular processes, including cell adhesion, migration, and survival.

One of the key features of LINC01765 is its expression level. The RNA is highly expressed in various tissues and cells, including brain, muscle, and cancer cells. This suggests that it may play a significant role in the biology of these cell types and could be a potential drug target or biomarker.

Another feature of LINC01765 is its gene expression pattern. The RNA is highly expressed in the brain and is downregulated in various tissues, including muscle and cancer cells. This suggests that it may be involved in the regulation of brain function and could be a potential drug target for neurological diseases.

In addition to its expression level and gene expression pattern, LINC01765 has also been shown to play a role in cellular signaling pathways. The RNA is highly expressed in the cell surface and has been shown to be involved in the regulation of cellular signaling pathways, including the NF-kappa pathway. This suggests that it may be involved in the development and progression of various diseases, including cancer.

Furthermore, LINC01765 has also been shown to have potential biomarker properties. The RNA is highly expressed in various tissues and has been shown to be associated with the development and progression of various diseases, including cancer. This suggests that it may be a potential biomarker for these diseases and could be used in diagnostic tools and therapeutic approaches.

In conclusion, LINC01765 is a long intergenic non-protein coding RNA that has potential drug target and biomarker properties. Further research is needed to fully understand its role in various cellular processes and to determine its potential as a drug target or biomarker.

Protein Name: Long Intergenic Non-protein Coding RNA 1765

The "LINC01765 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LINC01765 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets